XXXX -producing @entity356 with enteroblastic differentiation.

@entity1 @entity5 @entity2970 @entity189 @entity160 @entity157 @entity356
BACKGROUND: @entity160 ( @entity160 ) is a useful @entity5 marker for @entity157 and @entity2970 . Recently, elevations of serum @entity160 were reported in @entity1 with other @entity5 , especially @entity356 . Two distinct @entity5 morphologies, hepatoid and clear cell, have been correlated with @entity160 production. METHODS: Two @entity1 with @entity160 -producing @entity356 were evaluated with immunohistochemical, ultrastructural, and biochemical studies. RESULTS: In @entity1 1, the primary and metastatic @entity189 consisted homogeneously of @entity189 with clear cytoplasm. In @entity1 2, the @entity5 was composed of three different areas: @entity189 with clear cytoplasm, @entity5 cartilage, and so-called @entity189 . The morphologic characteristics of @entity189 with clear cytoplasm were similar to those of the developing gut epithelium at the stage of 2-4 months' gestation. The elution patterns of the serum @entity160 on lectin-affinity sepharose column study also suggested a correlation with fetal gut differentiation. CONCLUSIONS: @entity160 -producing clear cell @entity356 are differentiated into fetal intestine. One @entity1 also had hepatocytic and cartilaginous differentiation, indicative of a blastomatous characteristic of the @entity5 . These @entity5 arose in association with intestinal metaplasia.
